Your browser doesn't support javascript.
loading
Anti-NKG2C/IL-15/anti-CD33 killer engager directs primary and iPSC-derived NKG2C+ NK cells to target myeloid leukemia.
Chiu, Emily; Felices, Martin; Cichocki, Frank; Davis, Zachary; Wang, Hongbo; Tuninga, Katie; Vallera, Daniel A; Lee, Tom; Bjordahl, Ryan; Malmberg, Karl Johan; Valamehr, Bahram; Miller, Jeffrey S.
Afiliação
  • Chiu E; Medical School, University of Minnesota, Minneapolis, MN, USA.
  • Felices M; Hematology, Oncology, and Transplantation, Mayo Clinic, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Cichocki F; Hematology, Oncology, and Transplantation, Mayo Clinic, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Davis Z; Hematology, Oncology, and Transplantation, Mayo Clinic, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Wang H; Hematology, Oncology, and Transplantation, Mayo Clinic, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Tuninga K; Hematology, Oncology, and Transplantation, Mayo Clinic, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Vallera DA; Department of Radiation Oncology, University of Minnesota, Minneapolis, MN, USA.
  • Lee T; Fate Therapeutics, San Diego, CA, USA.
  • Bjordahl R; Fate Therapeutics, San Diego, CA, USA.
  • Malmberg KJ; Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden.
  • Valamehr B; Fate Therapeutics, San Diego, CA, USA.
  • Miller JS; Hematology, Oncology, and Transplantation, Mayo Clinic, Minneapolis, MN, USA; Department of Medicine, University of Minnesota, Minneapolis, MN, USA. Electronic address: mille011@umn.edu.
Mol Ther ; 29(12): 3410-3421, 2021 12 01.
Article em En | MEDLINE | ID: mdl-34174441
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Células-Tronco Pluripotentes Induzidas Limite: Humans Idioma: En Revista: Mol Ther Assunto da revista: BIOLOGIA MOLECULAR / TERAPEUTICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos